Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx

Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle · 2024

Read Improving Affordability in Dermatology: Cost Savings in Mark Cuban Cost Plus Drug Company Versus GoodRx by Christopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle (2024) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-11661688.txt.

Description

Christopher Youn and co-authors compare in 2024 skin drug prices at the Mark Cuban Cost Plus Drug Company against GoodRx prices. High drug costs burden many patients with skin disease. The cost analysis finds that Cost Plus pricing holds strong promise to cut what patients pay out of pocket for dermatology drugs.

Catalog record

CREATORChristopher G Youn, Joo Yeon Kim, Vivian B Yang, Gordon H Bae, Robert Dellavalle
YEAR2024
COLLECTIONPAPERS
FORMATTXT
FILE SIZE9 KB
VERSION1.0
LICENSECC BY 4.0
RIGHTSCC BY
SOURCEEurope PMC

Source: https://europepmc.org/articles/PMC11661688

Browse the full library · About the Tower of Babel